可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]蒋 明,David YU,林孝义,等.中华风湿病学[M].北京:华夏出版社,2004:738-748.
[2]Avina-Zubieta JA,Thomas J,Sadatsafavi M,et al.Risk of incident cardiovascular events in patients with rheumatoid arthritis:a meta-analysis of observational studies[J].Ann Rheum Dis,2012,6(9):1524-1529.
[3]Gabriel SE,Crowson CS,Kremers HM,et al. Survival in rheumatoid arthritis:a population-based analysis of trends over 40 years[J].Arthritis Rheum,2003,48(1):54-58.
[4]Ridker PM,Paynter NP,Rifai N,et al.C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men[J].Circulation,2008,118(22):2243-2251.
[5]中华医学会风湿病学分会,类风湿关节炎诊断及治疗指南[J].中华风湿病学杂志,2012,16(2):4-5.
[6]Full LE,Monaco C.Targeting inflammation as a therapeutic strategy in accelerated atherosclerosis in rheumatoid arthritis[J].Cardiovasc Ther,2011,29(4):231-242.
[7]Roldan CA,Delong C,Qualls CR,et al.Characterization of valvular heart disease in rheumatoid arthritis by transesophageal echocardiography and clinical correlates[J].Am J Cardiol,2007,100(3):496-502.
[8]Kremers HM,Crowson CS,Snyder MR,et al.Autoantibodies and the risk of cardiovascular events[J].J Rheumatol,2009,36(11):2462-2469.
[9]Humphreys JH,van Nies J,Chipping J,et al.Rheumatoid factor and anti-citrullinated protein antibody positivity, but not level, are associated with increased mortality in patients with rheumatoid arthritis: results from two large independent cohorts[J].Arthritis Res Ther,2014,16(6):483.
[10]Bisoendial RJ,Levi M,Tak PP,et al.The prothrombotic state in rheumatoid arthritis:an additive risk factor for adverse cardiovascular events[J].Semin Thromb Hemost,2010,36(4):452-457.
[11]Koller L,Kleber M,Goliasch G,et al.C-reactive protein predicts mortality in patients referred for coronary angiography and symptoms of heart failure with preserved ejection fraction[J].Eur J Heart Fail,2014,16(7):758-766.